Authored by Mikaella de Oliveira
Our bodies are constantly throwing off subtle clues about what’s going on beneath the surface, but modern medtech still struggles to read a lot of them. Biomarkers are measurable biological signals, like specific proteins, hormones or genetic material, that give doctors a better idea of what is actually inside the body.
As someone currently being “treated” for endometriosis, I know firsthand how strange it feels to live with a condition that impacts your everyday life when there is currently no cure for it. But endometriosis is just one example of why researchers are looking for better ways to understand women’s health. Biomarkers could help doctors track diseases, see if treatments are working and potentially spot changes earlier.
So, What Is A Biomarker?
Biomarkers are measurable clues found inside the body. Scientists can look for these biological signals in things like blood, urine or tissue.
They can be used to monitor existing illness, see how disease changes over time or check whether someone is responding to a particular treatment. These signals can reveal more about what’s happening inside a body, but the challenge is making sure they actually tell doctors something useful.
Finding a biological signal linked to a condition doesn’t automatically make it a reliable medical test. Researchers need to figure out how accurate and consistent it is before doctors can use it as part of routine care. A marker might show a connection to a disease in research without being accurate enough to diagnose that disease in an individual patient.
More from MedTech
Could Biomarkers Help With Endometriosis?
The potential uses of biomarkers don’t necessarily end once a condition has been identified. Researchers are also interested in whether biological signals could help show how a disease is changing or how different patients respond to treatment.
That could eventually make treatment more personalised. Instead of looking only at symptoms and deciding whether something appears to be working, doctors could potentially have biological information to consider alongside them. For a condition like endometriosis, where symptoms and experiences can vary significantly between patients, having more information could make treatment decisions more informed.
We are still a long way from biomarkers being used this way as standard care. But, research into blood-based signals is already moving toward clinical testing, with a 2025 study reported by Nature investigating whether microRNA could be turned into a non-invasive diagnostic test for endometriosis.
Could Biomarkers Give Women More Hope?
There’s something reassuring about seeing researchers look for answers to questions that medicine still can’t fully answer. Biomarkers are still being tested and refined, but the possibility of finding measurable signs that can tell us more about conditions like endometriosis gives me hope that women’s healthcare can move beyond simply managing symptoms. After all, we can’t expect to solve problems until we’re asking the right questions.
I don’t expect a blood test to magically change everything overnight. But knowing that research is moving towards more precise ways of understanding what’s happening inside our bodies makes the future feel a little less uncertain. For anyone living with a condition that has no cure, that alone can mean a lot.
It is a reminder that even when medicine doesn’t have all the answers yet, researchers are still looking for them. And sometimes, knowing that the search is happening is enough to give women a little more hope for what comes next.
